• Company
• Korea's drug pricing system on US tariff on pharmaceuticals
• by Kim, Jin-Gu Apr 2, 2025 05:56am

• Company
• Olympus Korea appoints Tamai Takeshi as new head
• by Whang, byung-woo Apr 2, 2025 05:56am

• Company
• Sanofi launches new dosage form of Praluent with reimb
• by Whang, byung-woo Apr 2, 2025 05:56am

• Company
• 'Rezurock' for cGVHD can be prescribed at 'Big 5' hospitals
• by Eo, Yun-Ho Apr 2, 2025 05:56am

• Company
• Vaxneuvance's 'immunogenicity' brings competitive edge
• by Whang, byung-woo Apr 2, 2025 05:56am

• Company
• What are the remaining issues for Leclaza?
• by Moon, sung-ho Apr 1, 2025 05:53am

• Company
• Korea is a strategic key R&D site for Boehringer Ingelheim
• by Whang, byung-woo Apr 1, 2025 05:52am

• Policy
• First RSV vaccine Arexvy to soon be released in Korea
• by Lee, Hye-Kyung Apr 1, 2025 05:52am

• Company
• Tepmetko granted reimb for METex14+ NSCLC
• by Whang, byung-woo Apr 1, 2025 05:52am

• Policy
• KPBMA proposes 'drug shortages·API·AI new drug' budget
• by Lee, Jeong-Hwan Apr 1, 2025 05:52am